Tuesday, May 19, 2026 | 6:30 PM-8:30 PM EST
Hilton Orlando | 6001 Destination Pkwy. Orlando, FL 32819 | Orange Ballroom D-G
Learn from Leaders | Connect with Peers
MLI Dialogues | Nontuberculous Mycobacteria Lung Disease (NTM-LD): Advancing Detection, Optimizing Therapy, and Improving Patient Quality of Life at ATS 2026
NTM-LD is a rare but serious condition, most commonly caused by Mycobacterium avium complex (MAC), and disproportionately affects patients with underlying lung diseases such as bronchiectasis, chronic obstructive pulmonary disease (COPD), and asthma—leading to delayed diagnosis, progressive lung damage, and diminished quality of life.
Unlike traditional lectures, this Dialogues program brings attendees into the conversation. Through real-time audience interaction, multidisciplinary expert insights, and real-world patient cases, you’ll explore the complexities of NTM-LD alongside leading specialists in an engaging, studio-quality format. This expert-led activity will include discussion and audience-driven dialogue as participants will examine current and emerging treatment strategies, including approaches for recurrent infection, and explore how evidence-based therapeutic decision-making can optimize clinical outcomes and improve patient quality of life.
Meet Our Faculty
Kevin Winthrop, MD, MPH
Professor
Oregon Health & Science University
Portland, OR, USA
Rocio M. Hurtado, MD, DTM&H, FIDSA
Director, Mycobacterial Center
ID Division
Massachusetts General Hospital
Harvard Medical School
Boston, MA, USA
Doreen Addrizzo-Harris, MD
Fiona and Stanley Druckenmiller Professor of Pulmonary & Critical Care Medicine
Director, NYULH Bronchiectasis and NTM Program
New York, NY, USA
In-Person & Virtual Registration
ATS Registration NOT Required to Participate Virtually
If you’re unable to attend in-person, this ATS session will also be available via live stream on our social channels and via Zoom. Learners can still attend and earn credit for FREE if you join the session via the live stream options.
This activity is intended for pulmonologists and infectious disease clinicians, who care for patients with nontuberculous mycobacterial lung disease (NTM-LD) in the U.S.
- Welcome and Introduction
- Unraveling the Complexity and Epidemiology of NTM Lung Disease
- Clinical Presentation and Diagnosis of NTM-LD
- Management and Treatment of NTM-LD
- Conclusion
After completing this activity, the participant should be better able to:
- Describe the epidemiology and clinical burden of NTM-LD
- Identify patients at risk of NTM-LD using standard diagnostic tools such as radiological and microbiological analysis
- Apply current and emerging treatment options for NTM-LD, including those for recurrent infections based on the latest clinical data to enhance patient QoL
This activity is provided by MLI
Accreditation, Support and Credit
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.5 AMA PRA Category 1.5 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Continuing Certification Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
For Physicians requesting ABIM MOC or ABTS CC credit, the post-test and evaluation are required in their entirety as well as your ABIM or ABTS ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC/CC credit.
Notice to Diplomates: MLI will report any claimed MOC/Lifelong Learning points to the appropriate Board within 4 weeks of completing the activity. Please ensure that you have provided your Board ID number and MMDD of birth.
PA
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours and 0.5 contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
MIPS
Completion of this accredited CE activity will meet the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
Support Statement
Supported by an Educational Grant from Insmed.
Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Chair/Planner/Presenter
Kevin Winthrop, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: AN2, Boehringer Ingelheim, Insmed, MannKind, Paratek, Spero, Zambon
Research Funding/Support: AN2, Boehringer Ingelheim, Insmed, MannKind, Merck, Verona
Planner/Presenter
Doreen Addrizzo-Harris, MD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, Calnetix, MannKind, Paratek, Sanofi
Planner/Presenter
Rocio Hurtado, MD, DTM&H, FIDSA, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: Insmed (Ad Board)
Patient
Angie MacArthur has no relevant financial relationships with ineligible companies to disclose for this educational activity.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity, however, registration is required. In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. You will receive your certificate from Medical Learning Institute Inc.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.
About This Activity
Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.
Copyright © 2026 Medical Learning Institute Inc. All Rights Reserved.
Supported by an Educational Grant from Insmed.